Neuroceuticals
Latest round
- Series B
Last raised
- Jul 2017
Total raised
- $3M
Investors
- 3
About Neuroceuticals
Founded in 2009, Neuroceuticals Inc. specializes in creating medical devices aimed at improving cardiac health.60 mn.Neuroceuticals specializes in advanced medical devices, particularly focusing on its core product, the vagus nerve stimulation catheter system. This innovative system is designed to protect cardiac muscle and mitigate the effects of heart failure, addressing critical healthcare needs. It stimulates the vagus nerve to regulate heart function and targets a wide range of healthcare providers, hospitals, and clinics globally, especially in North America and Asia-Pacific.Neuroceuticals generates revenue through direct sales of its proprietary medical devices, primarily the vagus nerve stimulation catheter system, to healthcare institutions. The business model includes partnerships with larger medical device companies, facilitating broader distribution. Transactions occur on a B2B basis, with hospitals and medical facilities placing bulk orders. The company aims to expand its market presence, particularly in North America and Asia-Pacific, by introducing innovative products designed to address specific healthcare needs. The management is focused on launching these new medical devices within the next few years, leveraging the recent investment to bolster its product development and market expansion strategies.
Who invested in Neuroceuticals
3 investors across 2 rounds
See all investors in Neuroceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neuroceuticals
Who invested in Neuroceuticals?
Neuroceuticals has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neuroceuticals raised?
Neuroceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Neuroceuticals last raise money?
Neuroceuticals's most recent round on record is a Series B, in Jul 2017.
What does Neuroceuticals do?
Founded in 2009, Neuroceuticals Inc.
Where is Neuroceuticals headquartered?
Neuroceuticals is headquartered in Tokyo, Japan.
Which VCs invest in companies like Neuroceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Neuroceuticals's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Neuroceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.